Eli Lilly & Co. said its antibody-based drug prevented Covid-19 among many residents and staff of nursing homes and assisted-living facilities, results that point to the drug complementing vaccines while inoculations increase. The drug, called bamlanivimab, reduced the risk of both staff and residents getting sick with Covid-19 by about 57% compared with a placebo,… Continue reading Lilly Antibody Drug Prevents COVID-19 in Nursing Homes, Study Finds
Looking For Market Distribution? Download the Media Kit
